Specialist Referral for Hepatitis B
Patients with chronic hepatitis B should be referred to a hepatologist, gastroenterologist, or infectious disease specialist when they have elevated ALT and HBV DNA levels >2,000 IU/mL, or when they require evaluation for antiviral therapy. 1, 2
Target Specialists
The most recent EASL guidelines (2025) explicitly identify the appropriate specialists for HBV management 1:
- Hepatologists (first choice)
- Gastroenterologists
- Infectious disease specialists
- Internal medicine physicians (for general management)
- Transplant medicine physicians (when relevant)
When to Refer
Immediate Referral Criteria
Refer patients to a specialist when any of the following are present 2, 3:
- Elevated ALT with HBV DNA >2,000 IU/mL - These patients need evaluation for antiviral therapy
- Active hepatitis - Patients transitioning from inactive to active infection status
- Consideration for antiviral treatment - Any patient being evaluated for nucleoside analogue therapy
- Hepatocellular carcinoma screening - Men >40 years and women >50 years requiring alpha-fetoprotein testing and ultrasound surveillance
Special Populations Requiring Specialist Referral 4, 5
- HBsAg-positive patients being considered for immunosuppressive therapy (e.g., TNF-alpha inhibitors for psoriasis)
- Patients with isolated positive hepatitis B core antibody who need immunosuppression
- Pregnant individuals with chronic HBV
- Children with chronic HBV infection
- Coinfected patients (HIV, hepatitis C, or hepatitis D)
Primary Care Provider Role
Primary care physicians maintain a critical role in the HBV care cascade 1, 2, 3:
- Screening individuals with risk factors for HBV infection
- Administering hepatitis B vaccinations
- Monitoring all HBV patients with ALT/AST every 3-12 months for life (since chronic HBV is dynamic and patients can transition between phases)
- Referring appropriately when treatment thresholds are met
Common Pitfall to Avoid
The most critical gap identified is that two-thirds of patients with hepatitis B are unaware of their infection, and most healthcare providers do not screen appropriately 3. The 2025 guidelines emphasize universal adult HBV screening to address this cascade-of-care failure 5. Don't wait for symptoms—chronic HBV is typically asymptomatic but carries significant risk for cirrhosis and hepatocellular carcinoma.
Partnership Model
Build a collaborative partnership between primary care and specialists rather than completely transferring care 2, 6. Primary care providers continue longitudinal monitoring while specialists guide treatment decisions, creating a shared management approach that enhances outcomes for this lifelong infection.